Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-AM1977X Single and Multiple Ascending Dose Study in Healthy Adults
jRCT2080225163Phase 1Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in bacterial disease comparing lascufloxacin with Placebo (2 arms). Primary endpoints: Safety and tolerability of lascufloxacin, Pharmacokinetics of lascufloxacin and 1 more. Started Apr 2020; status: completed.
02
Drugs
lascufloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on jRCT2080225163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225163.